Formulation and Characterization of Fast Dissolving Oral Film of Ubrogepant
Abstract
The present study was undertaken to develop and evaluate fast-dissolving oral films of Ubrogepant for rapid drug release and improved convenience of oral administration. Ubrogepant-containing films were prepared by the solvent casting method using different film-forming polymers, including HPMC K4, HPMC K15, guar gum, xanthan gum, and sodium alginate. PEG 400 was incorporated as a plasticizer/solubilizing agent, while mannitol and citric acid were used as sweetening and saliva-stimulating agents, respectively. The prepared formulations were evaluated for general appearance, thickness, weight, folding endurance, disintegration time, tensile strength, moisture content, drug assay, and in-vitro drug release. The formulations showed a transparent appearance with thickness ranging from 48 ± 2 to 61 ± 5 µm and weight ranging from 90 ± 3 to 101 ± 6 mg. Folding endurance was found to be 142 ± 4 to 228 ± 3 times, while disintegration time ranged from 30 ± 2 to 68 ± 3 seconds. The drug assay was found to be within the range of 95.96 ± 0.48% to 99.36 ± 0.62%. Among the prepared formulations, F7 exhibited desirable film characteristics, the shortest disintegration time of 30 ± 2 seconds, and satisfactory drug assay of 99.36 ± 0.62%. The in-vitro drug release study showed that F7 released 99.42% of drug within 10 minutes. Release kinetic analysis showed the highest regression coefficient for the Peppas model (r² = 0.9866), followed by the Higuchi model (r² = 0.9785), indicating a diffusion-related drug-release mechanism. Thus, the optimized F7 formulation demonstrated suitable physicochemical characteristics, rapid disintegration, high drug content, and rapid drug release, indicating its potential as a fast-dissolving oral film formulation of Ubrogepant.

